| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $144K | +477.8% |
| Cost of Revenue | $101K | +561.1% |
| Gross Profit | $42K | +343.8% |
| R&D Expense | $44K | +0.0% |
| SG&A Expense | $770K | +137.6% |
| Operating Income | -$2.3M | -130.6% |
| Pre-tax Income | -$2.3M | -133.4% |
| Income Tax | $35K | — |
| Net Income | -$2.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $125K | +328.4% |
| Current Assets | $316K | +708.2% |
| Total Assets | $4.0M | — |
| Current Liabilities | $5.9M | +1632.8% |
| Total Liabilities | $5.9M | +1632.8% |
| Stockholders' Equity | -$1.8M | -508.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.9M | -109.6% |
| Capital Expenditures | $79K | — |
| Investing Cash Flow | -$1.9M | — |
| Financing Cash Flow | $3.9M | +423.4% |
| Free Cash Flow | -$2.0M | — |
| -136.9% |
| EPS (Basic) | -$0.02 | -100.0% |
| EPS (Diluted) | -$0.02 | -100.0% |